Enterol® (Enterol®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspPowder for suspension for oral administration
Composition:

In 1 bag contains:

Active ingredient: Saccharomyces boulardii lyophilizate 250 mg;

auxiliary components: lactose monohydrate 32.5 mg, fructose 471.9 mg, silicon dioxide colloid 6.25 mg, flavor of tutti-frutti 4.35 mg.

Description:

Light brown powder with a fruity aroma /

Pharmacotherapeutic group:eubiotic
ATX: & nbsp
  • Boulardii Saccharomycetes
    • Pharmacodynamics:

    A drug Saccharomyces boulardii is a probiotic, according to the definition of WHO, it is living microorganisms, applied in adequate quantities, which have a healing effect on the human body. Saccharomyces boulardii has antimicrobial effect, caused by antagonistic effect against pathogenic and conditionally pathogenic microorganisms: Clostridium difficile, Candida albicans, Candida kruesei, Candida pseudotropicalis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella typhimurium, Yersinia enterocolitica, Escherichia coli, Shigella dysenteriae, Staphylococcus aureus and others, as well as Entamoeba histolitica and Lambliae. Saccharomyces boulardii has an antitoxic effect against bacterial cytotoxic and enterotoxins, increases the enzymatic function of the intestine. Cell wall component Saccharomyces boulardii Mannitol is a substrate for pathogenic strains Escherichia coli and Salmonella typhimurium, which causes their adhesion (attachment) to the surface Saccharomyces boulardii and the subsequent excretion from the body. Saccharomyces boulardii has a natural resistance to antibiotics.

    Saccharomyces boulardii It is not an eubiotic; is not a part of the microflora of a healthy human body, respectively, after taking the drug Saccharomyces boulardii passes through the digestive tract unchanged without colonization and is completely eliminated from the body within 2-5 days after discontinuation of admission.

    Indications:

    Treatment and prevention of diarrhea of ​​various etiologies in adults and children from 1 year, incl. with dysbacteriosis, irritable bowel syndrome, enterocolitis, antibiotic-associated diarrhea, travelers' diarrhea, diarrhea caused by Clostridium difficile.

    Contraindications:

    Hypersensitivity to any of the components of the drug.

    The presence of a central venous catheter, since rare cases of fungemia in patients with a central venous catheter are described in hospital settings.

    Lactose intolerance, lactase deficiency, glucose-galactose malabsorption.

    Pregnancy and lactation:Data on the safety of the drug in pregnant women and during breastfeeding are absent.
    The use of the drug is possible if the intended use for the mother exceeds the potential risk to the fetus.
    Dosing and Administration:

    Inside for 1 or 2 bags 1 or 2 times a day for 1 hour before meals. The contents of the sachet can be mixed with water or another drink, and added to food or a bottle of baby food.

    Children from 1 year to 3 years - 1 packet twice a day.

    Children from 3 years and adults - 1-2 packs twice a day.

    For the treatment of acute diarrhea viral, bacterial or protozoal etiology the course of treatment is 5-10 days.

    To prevent antibiotic-associated diarrhea,Urs treatment on days corresponds to the course of antibiotic use.

    To prevent the recurrence of infection caused by Clostridium difficile, in combination with metronidazole or vancomycin, the course of treatment is 1 month. For the prevention of travelers' diarrhea, the treatment course by days corresponds to the duration of the trip.

    For the treatment of irritable bowel syndrome The drug should be continued until the symptoms disappear.

    Admission of the drug for the treatment of acute diarrhea must necessarily be accompanied by rehydration (plentiful drink).

    Side effects:

    In rare cases, individual sensitivity to the components of the drug may occur.

    If you notice any other side effects not listed in the instructions, tell your doctor.

    Overdose:

    Data on the drug overdose are not currently available.

    Interaction:

    Enterol® is not taken with antifungal drugs.

    Compatible with antibiotics.

    Special instructions:

    It is necessary to apply the drug with caution in individuals with immunodeficiencies.

    Do not drink with hot and alcoholic beverages. Do not heat mixed in a water or other beverage preparation in a microwave oven (microwave oven). Water or a drink, if necessary, is heated in a microwave oven, and then the preparation is added to warm water.

    If, after two days of using Enterol® to treat acute diarrhea, there is no improvement, as well as an increase in temperature, the detection of blood or mucus in the stool, you should immediately contact your doctor.

    Feeling of thirst and dry mouth testify to insufficient intake of fluid (rehydration).

    A drug whose package integrity is impaired, a drug without labeling, a drug with altered physical properties is unsuitable for use.

    Effect on the ability to drive transp. cf.and fur:

    There was no adverse effect of the use of Enterol® on the ability to drive and complex mechanisms.

    Form release / dosage:

    Powder for suspension for oral administration, 250 mg.

    Packaging:

    765 mg of powder is placed in a paper-polyethylene-aluminum bag.

    For 10 or 20 bags together with instructions for use are put in a cardboard box.

    For 6 bags are placed in a cardboard pack without the top face and 5 such packs are placed in a pack of cardboard along with instructions for use.

    Storage conditions:

    At a temperature of 15 to 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after the date shown on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-002433
    Date of registration:17.04.2014
    Date of cancellation:2019-04-17
    The owner of the registration certificate:BIOCODEX BIOCODEX France
    Manufacturer: & nbsp
    BIOCODEX France
    Representation: & nbspBIOCODEX BIOCODEX France
    Information update date: & nbsp31.01.2016
    Illustrated instructions
      Instructions
      Up